Back to company

Target Biotech ApS: Financial statements 2024

CVR: 39676478

Target Biotech ApS (CVR 39676478) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -25,407 and a net result of DKK 23,952,623 compared with DKK 3,926 the year before. Equity amounted to DKK 24,285,415. The solvency ratio was 99.9%. The company had 1 employee in the financial year.

Gross Profit
-25,407 kr.
Profit/Loss
23,952,623 kr.
Equity
24,285,415 kr.
Total Assets
24,310,611 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--25 t.24 mio.24.3 mio.1
2023-64 t.4 t.333 t.1
2022-403 t.57 t.329 t.1
2021-487 t.88 t.272 t.1
2020-365 t.24 t.184 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Target Biotech ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Target Biotech ApS: The 2023 annual report is outJul 1, 2024

Target Biotech ApS has published its annual report for 2023. Gross profit came to DKK 63,828, and the net result was DKK 3,926.

About Target Biotech ApS

Target Biotech ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Peter Horn Møller. The company is owned by Peter Horn Møller. The company has 0 employees. In 2025, the company reported a gross profit of DKK -19,344 and a net result of DKK -7,028,421 compared with DKK 23,952,623 the year before. Equity amounted to DKK 10,735,912.

Other financial years